Go to homepage
Holoclara
Holoclara
Overview
Overview
Governance
Governance
Press
Press
Contact
December 18, 2024
Holoclara’s announcement entering Phase 1 clinical trials and targeting Eosinophilic esophagitis is featured in Fierce Biotech.
Share
Share this article
